McMaster University

McMaster University

Faculty of
Health Sciences

Announcement — Chair, Department of Oncology, Faculty of Health Sciences

Mark Levine

Mark Levine, M.D., M.Sc., F.R.C.P(C)

June 28, 2012

From: John G. Kelton, MD, Dean and Vice-President, Faculty of Health Sciences

It is with pleasure that I announce the reappointment of Dr. Mark Levine as chair, Department of Oncology effective July 1, 2012. 

Mark Levine is a professor in the Department of Oncology at McMaster University. He holds the Buffett Taylor Chair in Breast Cancer Research at McMaster.  He is a past recipient of the O. Harold Warwick Prize (1999) from the Canadian Cancer Society Research Institute.  Dr. Levine received his medical degree from McGill University and completed his residency in internal medicine at McMaster University.  He completed his training in hematology and oncology at Duke University Medical Centre. In addition, Dr. Levine received a master’s degree in clinical epidemiology and biostatistics from McMaster University.

In 1982, Dr. Levine became a member of both the Faculty of Health Sciences at McMaster University, and a medical oncologist at the Hamilton Regional Cancer Centre (now known as the Juravinski Cancer Centre of the Hamilton Health Sciences). He was CEO of the Cancer Centre between 1992 and 1999. 

Over the past 29 years he has been an active researcher in clinical trials and health services research.  His focus is in the areas of breast cancer, thromboembolism in malignancy and functional imaging.  A number of the trials he has conducted have impacted on health care in both Canada and internationally.  He helped establish the Ontario Clinical Oncology Group (OCOG) in 1982 and now is the director.  OCOG is an academic group that designs, coordinates and analyses multicentre trials in cancer.  Dr. Levine has over 250 publications in peer-reviewed journals and has brought much research funding to McMaster. 

He was chairman of Health Canada’s steering committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.  Dr. Levine was an associate editor of the Journal of Clinical Oncology for seven years and now is a consultant editor.

News Story

Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0